Raloxifene
Raloxifene hydrochloride is an estrogen agonist/antagonist indicated for: Treatment and prevention of osteoporosis in postmenopausal women. ( 1.1 ) Reduction in risk of invasive breast cancer in postmenopausal women with osteoporosis.
United States
$19
per month
India
$4
per month
You save
−80%save $15/mo · 80% cheaper
710.2K US scripts/yr$11M potential annual savings$13.7M US spend/yr
Drag to rotate · 3D structureC28H27NO4S
SMILES: C1CCN(CC1)CCOC2=CC=C(C=C2)C(=O)C3=C(SC4=C3C=CC(=C4)O)C5=CC=C(C=C5)O
Compare the price
US price$19per month
India price$4per month
You save$1580% less
Based on 30 units per month. US $0.64 vs India $0.13 per unit.
Total over 1 periodSave $15$19 → $4
The bigger picture
Raloxifene is filled about 710.2K times a year under Medicare Part D. At the prices above, that works out to roughly:
Est. annual US spend
$13.7M
If sourced from India
$2.7M
Potential annual savings
$11M
−80%
Rough estimate. Based on Medicare Part D prescription volume (not the entire US market) scaled by the representative monthly price — actual totals depend on dose, duration and coverage.